Astra’s Potential Blockbuster Blood Pressure Pill Approved in US

AstraZeneca Plc’s new hypertension pill won US Food and Drug Administration approval in a boost for the drugmaker that’s seeking to garner more than $5 billion in annual sales from the medicine.

The drug, called Baxfendy, significantly lowered blood pressure when added to other hypertension medicines in clinical trials. The regulator cleared it for patients who aren’t adequately controlled with existing treatments.